Los Angeles Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-76,725
| Closed | -$233K | – | 1263 |
|
|
2024
Q4 | $233K | Sell |
76,725
-13,100
| -15% | -$39.8K | ﹤0.01% | 1011 |
|
|
2024
Q3 | $466K | Sell |
89,825
-26,543
| -23% | -$138K | ﹤0.01% | 879 |
|
|
2024
Q2 | $299K | Buy |
116,368
+23,450
| +25% | +$60.3K | ﹤0.01% | 1016 |
|
|
2024
Q1 | $457K | Buy |
+92,918
| New | +$457K | ﹤0.01% | 898 |
|
|
2023
Q4 | – | Sell |
-18,976
| Closed | -$218K | – | 1263 |
|
|
2023
Q3 | $218K | Buy |
18,976
+10,446
| +122% | +$120K | ﹤0.01% | 1051 |
|
|
2023
Q2 | $216K | Buy |
+8,530
| New | +$216K | ﹤0.01% | 1104 |
|
|
2019
Q2 | – | Sell |
-16,759
| Closed | -$264K | – | 1447 |
|
|
2019
Q1 | $264K | Sell |
16,759
-27,331
| -62% | -$431K | ﹤0.01% | 1232 |
|
|
2018
Q4 | $888K | Sell |
44,090
-520
| -1% | -$10.5K | 0.01% | 776 |
|
|
2018
Q3 | $1.11M | Buy |
44,610
+1,710
| +4% | +$42.5K | 0.01% | 836 |
|
|
2018
Q2 | $1.18M | Buy |
+42,900
| New | +$1.18M | 0.01% | 845 |
|